CHRISTINA KERNS: Open Payments
NPI 1417353343 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,716 in 180 payments from 27 companies in 2025. Trend: 2023 $2,005 · 2024 $1,753 · 2025 $2,716
Food & beverage: $2,566Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $388 |
| JAZZ PHARMACEUTICALS INC. | 7 | $275 |
| Neurocrine BioSciences, Inc. | 12 | $231 |
| Axsome Therapeutics, Inc. | 15 | $197 |
| Vanda Pharmaceuticals Inc. | 4 | $180 |
| PFIZER INC. | 21 | $172 |
| EMD Serono, Inc. | 9 | $170 |
| UCB, Inc. | 11 | $166 |
| Teva Pharmaceuticals USA, Inc. | 10 | $163 |
| Celgene Corporation | 6 | $109 |
Products named: XYWAV, INGREZZA, PONVORY, AUSTEDO XR, QULIPTA, UBRELVY, Rystiggo, NURTEC ODT.
Industry payments across MO — which companies pay providers there.
